HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Numan Adds Automation To Its Digital Consumer Health Offer With Vi-Health Acquisition

Executive Summary

UK men's health platform Numan continues its mission of disrupting the consumer health industry with its acquisition of Sweden’s Vi-Health technology – a Class I medical device that includes an artificial intelligence-powered symptom checker, as well as advanced e-consultation and workflow automation tools.

You may also be interested in...



How A UK Tech Start-Up Is Disrupting Men’s Health

HBW Insight talks to Numan's chief medical strategy officer Professor Sam Shah about how the UK tech start-up is bringing innovation to the country's men's health category. 

Consumer Health Industry Ideally Placed To Lead And Benefit From Climate Fight

Consumer healthcare firms are perfectly placed to lead the charge in fighting climate change while benefitting from the transition to a greener, healthier world. However, taking advantage of the green opportunity means putting environmental, social and governance (ESG) at the center of how OTC companies measure and reward success and treating the health of people and planet as a single, related issue, argues Bayer Consumer Health's sustainability guru Daniella Foster. 

WHO Support A Game-Changer For Emerging Global Self-Care Movement, Resolution 'Likely'

Working alongside the consumer healthcare industry, the Self-Care Academic Research Unit (SCARU) is helping to build a global self-care movement that makes a World Health Organization resolution "very likely" in the next few years, says director Austen El-Osta.

Topics

UsernamePublicRestriction

Register

RS151196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel